Allovir, Inc. Annual Current Income Tax Expense (Benefit) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Allovir, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from 2021 to 2023.
  • Allovir, Inc. Current Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Allovir, Inc. Current Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -$265K, a 126% decline year-over-year.
  • Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2023 was -$126K, a 52.5% increase from 2022.
  • Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2022 was -$265K, a 126% decline from 2021.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$126K +$139K +52.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$265K -$1.27M -126% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $1.01M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.